Changes in antibiotic resistance of the most common Gram-negative bacteria isolated in intensive care units

Journal of Hospital Infection

Volumn 60, Issue 3, 2005, Pages 245-248

  Makedou, Kali G ^a,b   Tsiakiri, E P ^a   Bisiklis, A G ^a   Chatzidimitriou, M ^a   Halvantzis, A A ^a   Ntoutsou, K ^a   Alexiou Daniel, S ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Acinetobacter; Antibiotic resistance; Gram negative bacteria; ICU; Klebsiella; Pseudomonas

Indexed keywords

AMIKACIN; CEFTAZIDIME; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; TOBRAMYCIN;

ACINETOBACTER CALCOACETICUS; AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA; STRAIN DIFFERENCE; STRAIN IDENTIFICATION;

ACINETOBACTER CALCOACETICUS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GREECE; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA;

EID: 20344382712     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2005.01.013     Document Type: Article

References (24)

1. L.G. Donowitz R.P. Wenzel J.W. Hoyt High risk of hospital acquired infection in the ICU patient Crit Care Med 10 1982 355-357
2. R.P. Wenzel R.L. Thompson S.M. Landry Hospital acquired infections in intensive care unit patients: An overview with emphasis on epidemics Infect Control 4 1983 371-375
3. J.M. Cristino Correlation between consumption of antimicrobials in humans and development of resistance in bacteria Int J Antimicrob Agents 12 1999 199-202
4. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 2000 NCCLS Wayne, PA [NCCLS document M7-A5]
5. H. Seifert R. Baginski A. Schulze Antimicrobial susceptibility of Acinetobacter species Antimicrob Agents Chemother 37 1993 750-753
6. I. Shalit M. Dan R. Gutman Cross resistance to ciprofloxacin and other antimicrobial agents among clinical isolates of Acinetobacter calcoaceticus biovar anitratus Antimicrob Agents Chemother 34 1990 494-495
7. M. Gehrlein H. Leying W. Cullmann Imipenem resistance in Acinetobacter baumanii is due to altered penicillin-binding proteins Chemotherapy 37 1991 405-412
8. B. Olson R.A. Weinstein C. Nathan Epidemiology of endemic Pseudomonas aeruginosa: Why infection control efforts have failed J Infect Dis 150 1984 808-816
9. B. Olson R.A. Weinstein C. Nathan Occult aminoglycoside resistance in Pseudomonas aeruginosa: Epidemiology and implications for therapy and control J Infect Dis 152 1985 769-774
10. G.L. French K.P. Shannon N. Simmons Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase J Clin Microbiol 34 1996 358-363
11. K. Shannon K. Fung P. Stapleton A hospital outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae investigated by RAPD typing and analysis of the genetics and mechanisms of resistance J Hosp Infect 39 1998 291-300
12. M.B. Macrae K.P. Shannon D.M. Rayner A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure J Hosp Infect 49 2001 183-192
13. L.D. Sabath Biochemical and physiologic basis for susceptibility and resistance of Pseudomonas aeruginosa to antimicrobial agents Rev Infect Dis 6 Suppl. 2 1984 S643-S656
14. J.P. Quinn A.E. Studemeister C.A. DiVincenzo Resistance to imipenem in Pseudomonas aeruginosa: Clinical experience and biochemical mechanisms Rev Infect Dis 10 1988 892-898
15. R.P. Gaynes D.H. Culver Resistance to imipenem among selected gram-negative bacilli in the United States Infect Cont Hosp Epidemiol 13 1992 10-14
16. R.C. George L.C. Ball P.B. Norbury Susceptibility to ciprofloxacin of nosocomial Gram-negative bacteria and staphylococci isolated in the UK J Antimicrob Chemother 26 Suppl. F 1990 145-156
17. I. Shalit H. Haas S.A. Berger Susceptibility of Pseudomonas aeruginosa to fluoroquinolones following four years of use in a tertiary care hospital J Antimicrob Chemother 30 1992 149-152
18. D.M. Livermore Clinical significance of β-lactamase induction and stable derepression in gram-negative rods Eur J Clin Microbiol 6 1987 439-445
19. J.M. Lodge L.J. Piddock The control of class I β-lactamase expression in Enterobacteriaceae and Pseudomonas aeruginosa J Antimicrob Chemother 28 1991 167-172
20. K.H. Mayer The epidemiology of antibiotic resistance in hospitals J Antimicrob Chemother 18 Suppl. C 1986 223-233
21. S. Knight M. Casewell Dissemination of resistance plasmids among gentamycin-resistant enterobacteria from hospital patients BMJ 283 1981 755-756
22. H.S. Sader M.A. Pfaller R.N. Jones Bacterial pathogens isolated from patients with bloodstream infections in Latin America, 1997: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program Brazil J Infect Dis 3 1999 97-110
23. M.A. Pfaller R.N. Jones G.V. Doern Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) Antimicrob Agents Ch 42 1998 1762-1770
24. K.P. Shannon G.L. French Increasing resistance to antimicrobial agents of Gram-negative organisms isolated at a London teaching hospital, 1995-2000 J Antimicrob Chemother 53 2004 818-825